Clinical Trials Browser

Terminated × Glioma × Everolimus × Clear all

NCT03352427 2022-10-05

Study of Dasatinib in Combination With Everolimus for Children and Young Adults With Gliomas Harboring Platelet-Derived Growth Factor Receptor (PDGFR) Alterations

Phase 2 Terminated

3 enrolled 7 charts

Glioma, Brain Stem Neoplasms